Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNG-IUS in Fertility-Preserving Treatment of EAH and Early EC
NCT03463252Phase 3Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Apr 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avatrombopag in endometrial cancer (EC), Atypical endometrial hyperplasia (AEH), sponsored by West China Second University Hospital. Started Apr 2018; status: recruiting.
02
Drugs
avatrombopag
03
Conditions
endometrial cancer (EC)Atypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT03463252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463252.